SCHEMBL27780320

SCHEMBL27780320

[CH2]CCc1c(Cl)cccc1[N+](=O)[O-]

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.52
KDM4E B2RXH2 2/20 0.52
LMNA P02545 2/20 0.46
CYP2C19 P33261 3/20 0.44
CYP1A2 P05177 2/20 0.44
CYP2C9 P11712 2/20 0.44
CYP3A4 P08684 2/20 0.44
CYP2D6 P10635 2/20 0.44
HPGD P15428 2/20 0.44
MAPT P10636 3/20 0.43
MAPK1 P28482 2/20 0.43
POLB P06746 1/20 0.43
TDP1 Q9NUW8 4/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
GPR35 Q9HC97 1/20 0.41
TSHR P16473 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
HTT P42858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11297092 0.87 TDP1 (0.50) ALDH1A1KDM4ECYP1A2HPGDMAPT
SCHEMBL7784647 0.84 ALDH1A1 (0.54) ALDH1A1KDM4ELMNACYP2C19CYP1A2
SCHEMBL5739265 0.83 ALDH1A1 (0.52) ALDH1A1KDM4ELMNACYP2C19CYP1A2
SCHEMBL4309273 0.83 ALDH1A1 (0.52) ALDH1A1KDM4ELMNACYP2C19CYP1A2
SCHEMBL10756135 0.80 ALDH1A1 (0.53) ALDH1A1KDM4ELMNACYP2C19CYP1A2
SCHEMBL29975243 0.80 ALDH1A1 (0.53) ALDH1A1KDM4ELMNACYP2C19CYP1A2
SCHEMBL3631215 0.80 ALDH1A1 (0.50) ALDH1A1KDM4ELMNACYP2C19CYP1A2
SCHEMBL27801663 0.79 TSHR (0.55) ALDH1A1KDM4ELMNAMAPTMAPK1
SCHEMBL27780340 0.79 MAPT (0.43) ALDH1A1KDM4ELMNACYP2C19CYP1A2
SCHEMBL5739943 0.79 ALDH1A1 (0.49) ALDH1A1KDM4ELMNACYP2C19CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101679299-A Nicotinic acid derivatives as modulators of metabotropic glutamate receptor-5 NOVARTIS AG 2010-03-24 CN disclosed